Cargando…
Pharmacokinetics/pharmacodynamics of L‐ornithine phenylacetate in overt hepatic encephalopathy and the effect of plasma ammonia concentration reduction on clinical outcomes
Hepatic encephalopathy (HE) is a serious neurocognitive complication of liver dysfunction, often associated with elevated plasma ammonia. Ornithine phenylacetate (OP), a potent ammonia scavenger, is being evaluated for the treatment of acute/overt HE. The pharmacokinetics and pharmacodynamics of OP...
Autores principales: | Safadi, Rifaat, Rahimi, Robert S., Thabut, Dominique, Bajaj, Jasmohan S., Ram Bhamidimarri, Kalyan, Pyrsopoulos, Nikolaos, Potthoff, Amy, Bukofzer, Stan, Wang, Laurene, Jamil, Khurram, Devarakonda, Krishna R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199870/ https://www.ncbi.nlm.nih.gov/pubmed/35238476 http://dx.doi.org/10.1111/cts.13257 |
Ejemplares similares
-
Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patients
por: Ventura-Cots, Meritxell, et al.
Publicado: (2016) -
Population Pharmacokinetic Analysis to Assist Dose Selection of the l-Ornithine Salt of Phenylacetic Acid
por: Wang, Xiaofeng, et al.
Publicado: (2021) -
Guanidinium 2-phenylacetate
por: Smith, Graham, et al.
Publicado: (2010) -
Validation of a Simple Quality‐of‐Life Score for Identification of Minimal and Prediction of Overt Hepatic Encephalopathy
por: Lauridsen, Mette Munk, et al.
Publicado: (2020) -
Ammonia rises from the ashes!
por: Weiss, Nicolas, et al.
Publicado: (2022)